HCPCS Level II · unclassified
Q2050 — Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
In short
Q2050 is the HCPCS Level II code for injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg: drugs with no specific code of their own. It has no fixed drug or unit, so the claim carries the NDC of the drug given and its quantity.
Code
CMS HCPCS file- Descriptor
- Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg
- Short descriptor
- Doxorubicin inj 10mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jul 1, 2013
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under Q2050
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 30 NDCs to Q2050 for Doxil, Doxorubicin HCl Liposome and Doxorubicin HCl, Liposomal. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Doxil | 00338-0063-01 | Baxter Healthcare Corporation | 10 | 2 |
| Doxil | 00338-0067-01 | Baxter Healthcare Corporation | 25 | 5 |
| Doxil | 00338-9665-01 | Baxter Healthcare Corporation | 25 | 5 |
| Doxil | 00338-9667-01 | Baxter Healthcare Corporation | 10 | 2 |
| Doxorubicin HCl Liposome | 68001-0629-26 | Bluepoint Laboratories | 25 | 5 |
| Doxorubicin HCl Liposome | 68001-0629-36 | Bluepoint Laboratories | 10 | 2 |
| Doxorubicin HCl, Liposomal | 16714-0742-01 | Northstar RxLLC | 10 | 2 |
| Doxorubicin HCl, Liposomal | 16714-0856-01 | Northstar RxLLC | 25 | 5 |
| Doxorubicin HCl, Liposomal | 25021-0263-10 | Sagent Pharmaceuticals | 10 | 2 |
| Doxorubicin HCl, Liposomal | 25021-0263-25 | Sagent Pharmaceuticals | 25 | 5 |
| Doxorubicin HCl, Liposomal | 43598-0283-35 | Dr. Reddy's Laboratories Inc. | 10 | 2 |
| Doxorubicin HCl, Liposomal | 43598-0541-25 | Dr. Reddy's Laboratories Inc. | 25 | 5 |
| Doxorubicin HCl, Liposomal | 43598-0682-35 | Dr. Reddy's Laboratories Inc. | 10 | 2 |
| Doxorubicin HCl, Liposomal | 43598-0683-25 | Dr. Reddy's Laboratories Inc. | 25 | 5 |
| Doxorubicin HCl, Liposomal | 47335-0049-40 | Sun Pharmaceutical Global FZE. | 10 | 2 |
| Doxorubicin HCl, Liposomal | 47335-0050-40 | Sun Pharmaceutical Global FZE. | 25 | 5 |
| Doxorubicin HCl, Liposomal | 68001-0345-26 | BluePoint Laboratories | 25 | 5 |
| Doxorubicin HCl, Liposomal | 68001-0345-36 | BluePoint Laboratories | 10 | 2 |
| Doxorubicin HCl, Liposomal | 68001-0492-36 | BluePoint Laboratories | 10 | 2 |
| Doxorubicin HCl, Liposomal | 68001-0493-26 | BluePoint Laboratories | 25 | 5 |
| Doxorubicin HCl, Liposomal | 68001-0703-36 | BluePoint Laboratories | 10 | 2 |
| Doxorubicin HCl, Liposomal | 68001-0704-26 | BluePoint Laboratories | 25 | 5 |
| Doxorubicin HCl, Liposomal | 70710-1530-01 | Zydus Pharmaceuticals (USA) Inc. | 10 | 2 |
| Doxorubicin HCl, Liposomal | 70710-1531-01 | Zydus Pharmaceuticals (USA) Inc. | 25 | 5 |
| Doxorubicin HCl, Liposomal | 70748-0339-01 | Lupin Pharmaceuticals, Inc. | 10 | 2 |
| Doxorubicin HCl, Liposomal | 70748-0340-01 | Lupin Pharmaceuticals, Inc. | 25 | 5 |
| Doxorubicin HCl, Liposomal | 72603-0103-01 | Northstar RxLLC | 10 | 2 |
| Doxorubicin HCl, Liposomal | 72603-0200-01 | Northstar RxLLC | 25 | 5 |
| Doxorubicin HCl, Liposomal | 75907-0363-01 | Dr. Reddy's Laboratories Inc. | 10 | 2 |
| Doxorubicin HCl, Liposomal | 75907-0364-01 | Dr. Reddy's Laboratories Inc. | 25 | 5 |
Q2050: common questions
- Is Q2050 a CPT code?
- No. Q2050 is a HCPCS Level II code, maintained by CMS, that identifies a drug with no specific code of its own. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDC goes with Q2050?
- None is fixed. Q2050 is used for drugs that have no specific HCPCS code, so the claim carries the NDC of the drug actually given and its quantity, and payers usually also ask for the drug name and dose. How to find a J-code.
- What is the Medicare payment limit for Q2050?
- $97.823 per 10 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.